Progress and prospects of mRNA-based drugs in pre-clinical and clinical applications
{{output}}
In the last decade, messenger ribonucleic acid (mRNA)-based drugs have gained great interest in both immunotherapy and non-immunogenic applications. This surge in interest can be largely attributed to the demonstration of distinct advantages offered by various... ...
